Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442050 · ClinicalTrials.gov registry record · NA
Del Nido Cardioplegia Randomized Trial
A NA study, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- NA
- Development phase
- 99
- Enrollment target
NCT02442050: Clinical Trial NA study, sponsored by Inova Health Care Services.
NCT02442050 is a NA study that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 99 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02442050, a NA study, was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
Study Summary
The use of a modified depolarizing cardioplegia solution in adult cardiac surgery would allow for prolonged re-dosing intervals while providing equivalent myocardial protection. The use of del Nido solution has been used extensively in congenital heart surgery for over 25 years. The primary objective is to determine whether expanding this technique to adult cardiac surgery will confer significant benefits in both surgical workflow and patient clinical outcome. The investigators hypotheses with regard to the del Nido solution will demonstrate (1) a non-inferior delivery to the current blood-based cardioplegia strategy in functional recovery or clinical outcome, and (2) superior delivery to the current blood-based cardioplegia strategy in cost analyses.
Primary Outcome
Return to spontaneous sinus rhythm measured as yes or no
Interventions
- OTHER del Nido solution
- OTHER Blood-based cardioplegia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-04-04 |
| Phase | NA |
Why NCT02442050 stopped before completion
NCT02442050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which del Nido solution is the first listed.
NCT02442050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02442050 about?
NCT02442050 is a clinical study titled "Del Nido Cardioplegia Randomized Trial". The use of a modified depolarizing cardioplegia solution in adult cardiac surgery would allow for prolonged re-dosing intervals while providing equivalent myocardial protection. The use of del Nido solution has been used extensively in congenital heart surgery for over 25 years. The primary objectiv...
What is the current status of trial NCT02442050?
This trial is currently terminated. It is a NA study. The enrollment target is 99 participants. The study started on 2015-01. Estimated completion is 2017-04-04.
What interventions are being tested in trial NCT02442050?
The interventions under investigation include: del Nido solution (OTHER), Blood-based cardioplegia (OTHER).
Who is sponsoring clinical trial NCT02442050?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02442050's enrollment target sits among peer trials
99 920th of 2000 higher than 1,079 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia